Medical Tubing Market by Material (Plastics, Rubbers, Specialty Polymers), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems), Structure (Single-Lumen, Multi-Lumen, Co-Extruded, Tapered or Bump, Braided) - Global Forecast to 2030
The medical tubing market is projected to reach USD 18.41 billion by 2030 from USD 12.53 billion in 2025, at a CAGR of 8.0% during the forecast period. The expansion in the medical tubing market is due to rise in cases of chronic disease, including cardiovascular conditions, cancer, and respiratory conditions. Many of these illnesses demand medical equipment like catheters, infusion equipment, and ventilators that involve tubing for treatment and management effectiveness. For example, increasing prevalence of respiratory conditions such as asthma and tuberculosis has promoted demand for ventilator tubing systems. The rise in the elderly population, also more prone to chronic diseases and surgery, is another major reason. This increase in the old age population led to an uptrend in need for minimally invasive procedures with medical tubing featuring a key element in drug administration and fluid delivery systems. Moreover, companies' strategic moves, including product launches and mergers, are broadening market coverage and visibility. Finally, rigorous regulatory requirements and government spending on healthcare infrastructure are driving market growth by providing high-quality tubing products for various applications. All these factors together put the medical tubing market in line for long-term growth in the next few years.
“Rubber is the second fastest-growing material in the medical tubing market during the forecast period.”
Rubber is the second fastest-growing medical tubing material because of its better flexibility, durability, and biocompatibility, which make it suitable for numerous medical applications. Natural and synthetic rubbers, including silicone, latex, and thermoplastic elastomers (TPE), provide good resistance to harsh temperatures, chemicals, and multiple sterilization cycles. This makes rubber tubing ideally suited to be used in catheters, respiratory therapy units, peristaltic pumps, and surgery drainage systems. Silicone rubber is specifically used on a large scale owing to its superior biocompatibility, for which it is considered a material of choice for implantable and long-term medical uses. In addition, rubber products have higher resilience that allows medical tubing to withstand bending and stretching without loss of integrity, hence offering enhanced patient comfort and device performance. The growing prevalence of chronic conditions, such as cardiovascular and respiratory diseases, has fueled the demand for medical devices that incorporate rubber tubing. In addition, advances in rubber formulations, including antimicrobial coatings and increased tensile strength, have contributed to its applications in critical care. With advances in healthcare innovation, rubber tubing continues to be a top contender, thus qualifying it as the second fastest-growing material in the medical tubing market.
“Braided tubing is the second fastest-growing structure in the medical tubing market during the forecast period.”
Braided tubing is the second fastest-growing medical tubing structure because of its excellent combination of strength, flexibility, and versatility that can address a broad spectrum of sophisticated medical uses. Its structure, with a reinforcing braided layer commonly composed of materials such as stainless steel or nylon inserted inside polymer tubing, provides the best resistance to high pressure and kinking than its non-reinforced counterparts. This makes it most appropriate for high-performance applications such as catheters, endoscopes, and cardiovascular devices, where durability and precise fluid delivery are of the highest priority. The growing need for minimally invasive procedures, which require tubing that can navigate through intricate anatomical pathways without compromising performance, significantly enhances its application. Braided tubing can withstand sterilization processes and maintain structural integrity under stress conditions also helps in meeting the strict safety requirements of the medical sector. Rising prevalence of chronic diseases, coupled with the aging population and their requirement for advanced diagnostic and therapeutic equipment, also fuels its market growth. New braiding technology and material science enable it to be even more flexible and enable customization to fulfill particular medical needs. While single-lumen tubing may be the culprit by way of simplicity and ubiquity, the greater mechanical properties and biocompatibility of braided tubing with high-performance uses position it as a fast-rising market that responds well to shifting needs of modern healthcare.
“Catheters & cannulas is the second fastest-growing structure in the medical tubing market during the forecast period.”
The catheters & cannulas market is the second fastest-growing application of the medical tubing market owing to a number of major driving factors behind its demand. As the global healthcare systems focus on minimally invasive interventions, catheters & cannulas are becoming the tools of choice, providing safer and less traumatic alternatives to conventional surgeries. These soft tubes play a vital role in uses such as cardiovascular interventions, urinary drainage, and intravenous therapy, where accuracy and patient comfort are of utmost importance. Growing prevalence of chronic illness, including cardiovascular conditions, diabetes, and renal disorders, mainly in aging communities, also catalyzes such expansion. Demand for catheterization in treatment of heart problems or urinary incontinence automatically increases demand for special tubing. Advancements in technology also are contributing factors with improved biocompatible materials, including silicone and polyurethane, improving functionality, longevity, and safety for catheters & cannulas. Besides, the move towards outpatient treatment and home healthcare increases their application in portable equipment, like infusion pumps. The segment is helped by the increasing investments in healthcare, particularly in sectors that are emerging, as enhanced infrastructure and availability of medical services increase the demand for disposable and sterile tubing.
“The Middle East and Africa (MEA) market is projected to register the second fastest growing market for medical tubing during the forecast period.”
Middle East & Africa (MEA) is the second fastest-growing market for medical tubing owing to mounting healthcare investment, enhancing medical infrastructure, and rising demand for high-tech medical devices. Regional governments, specifically those of Saudi Arabia, UAE, and South Africa, are greatly investing in the modernization of healthcare, generating the demand for superior medical tubing for usage in hospitals, clinics, and diagnostic centers. The growth of healthcare facilities, coupled with the creation of medical free zones and manufacturing centers, is increasing local production and distribution of medical tubing and associated devices. The increasing incidence of chronic diseases like diabetes, cardiovascular diseases, and respiratory diseases has boosted the use of medical tubing in drug delivery systems, catheters, and respiratory devices. The increased geriatric population in the region also demands advanced medical treatment, thereby propelling the use of medical tubing-based applications. The transition towards home healthcare and wearable medical devices, including insulin pumps and oxygen therapy devices, is another key driver for market growth. Worldwide medical device companies are expanding their reach in the MEA region through collaborations, joint ventures, and establishing regional production units. All this growth increases the number of better-quality medical tubing products available and reduces dependency on imports, and consequently healthcare becomes affordable. Medical tubing technologies such as biodegradable and antimicrobial medical tubing grow more popular in MEA as healthcare professionals continue to prioritize infection control and eco-friendliness.
Extensive primary interviews were conducted to determine and verify the market size for several segments and sub-segments and the information gathered through secondary research.
The break-up of primary interviews is given below:
Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), Teknor Apex (US), Spectrum Plastics Group (US) Zeus Company LLC (US) among others are some of the key players in the medical tubing market.
The study includes an in-depth competitive analysis of these key players in the authentication and brand
protection market, with their company profiles, recent developments, and key market strategies.
Research Coverage
The market study covers the medical tubing market across various segments. It aims to estimate the market size and the growth potential of this market across different segments based on material, application, structure, end-use industry, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the medical tubing market.
Key Benefits of Buying the Report
The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall medical tubing market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
“Rubber is the second fastest-growing material in the medical tubing market during the forecast period.”
Rubber is the second fastest-growing medical tubing material because of its better flexibility, durability, and biocompatibility, which make it suitable for numerous medical applications. Natural and synthetic rubbers, including silicone, latex, and thermoplastic elastomers (TPE), provide good resistance to harsh temperatures, chemicals, and multiple sterilization cycles. This makes rubber tubing ideally suited to be used in catheters, respiratory therapy units, peristaltic pumps, and surgery drainage systems. Silicone rubber is specifically used on a large scale owing to its superior biocompatibility, for which it is considered a material of choice for implantable and long-term medical uses. In addition, rubber products have higher resilience that allows medical tubing to withstand bending and stretching without loss of integrity, hence offering enhanced patient comfort and device performance. The growing prevalence of chronic conditions, such as cardiovascular and respiratory diseases, has fueled the demand for medical devices that incorporate rubber tubing. In addition, advances in rubber formulations, including antimicrobial coatings and increased tensile strength, have contributed to its applications in critical care. With advances in healthcare innovation, rubber tubing continues to be a top contender, thus qualifying it as the second fastest-growing material in the medical tubing market.
“Braided tubing is the second fastest-growing structure in the medical tubing market during the forecast period.”
Braided tubing is the second fastest-growing medical tubing structure because of its excellent combination of strength, flexibility, and versatility that can address a broad spectrum of sophisticated medical uses. Its structure, with a reinforcing braided layer commonly composed of materials such as stainless steel or nylon inserted inside polymer tubing, provides the best resistance to high pressure and kinking than its non-reinforced counterparts. This makes it most appropriate for high-performance applications such as catheters, endoscopes, and cardiovascular devices, where durability and precise fluid delivery are of the highest priority. The growing need for minimally invasive procedures, which require tubing that can navigate through intricate anatomical pathways without compromising performance, significantly enhances its application. Braided tubing can withstand sterilization processes and maintain structural integrity under stress conditions also helps in meeting the strict safety requirements of the medical sector. Rising prevalence of chronic diseases, coupled with the aging population and their requirement for advanced diagnostic and therapeutic equipment, also fuels its market growth. New braiding technology and material science enable it to be even more flexible and enable customization to fulfill particular medical needs. While single-lumen tubing may be the culprit by way of simplicity and ubiquity, the greater mechanical properties and biocompatibility of braided tubing with high-performance uses position it as a fast-rising market that responds well to shifting needs of modern healthcare.
“Catheters & cannulas is the second fastest-growing structure in the medical tubing market during the forecast period.”
The catheters & cannulas market is the second fastest-growing application of the medical tubing market owing to a number of major driving factors behind its demand. As the global healthcare systems focus on minimally invasive interventions, catheters & cannulas are becoming the tools of choice, providing safer and less traumatic alternatives to conventional surgeries. These soft tubes play a vital role in uses such as cardiovascular interventions, urinary drainage, and intravenous therapy, where accuracy and patient comfort are of utmost importance. Growing prevalence of chronic illness, including cardiovascular conditions, diabetes, and renal disorders, mainly in aging communities, also catalyzes such expansion. Demand for catheterization in treatment of heart problems or urinary incontinence automatically increases demand for special tubing. Advancements in technology also are contributing factors with improved biocompatible materials, including silicone and polyurethane, improving functionality, longevity, and safety for catheters & cannulas. Besides, the move towards outpatient treatment and home healthcare increases their application in portable equipment, like infusion pumps. The segment is helped by the increasing investments in healthcare, particularly in sectors that are emerging, as enhanced infrastructure and availability of medical services increase the demand for disposable and sterile tubing.
“The Middle East and Africa (MEA) market is projected to register the second fastest growing market for medical tubing during the forecast period.”
Middle East & Africa (MEA) is the second fastest-growing market for medical tubing owing to mounting healthcare investment, enhancing medical infrastructure, and rising demand for high-tech medical devices. Regional governments, specifically those of Saudi Arabia, UAE, and South Africa, are greatly investing in the modernization of healthcare, generating the demand for superior medical tubing for usage in hospitals, clinics, and diagnostic centers. The growth of healthcare facilities, coupled with the creation of medical free zones and manufacturing centers, is increasing local production and distribution of medical tubing and associated devices. The increasing incidence of chronic diseases like diabetes, cardiovascular diseases, and respiratory diseases has boosted the use of medical tubing in drug delivery systems, catheters, and respiratory devices. The increased geriatric population in the region also demands advanced medical treatment, thereby propelling the use of medical tubing-based applications. The transition towards home healthcare and wearable medical devices, including insulin pumps and oxygen therapy devices, is another key driver for market growth. Worldwide medical device companies are expanding their reach in the MEA region through collaborations, joint ventures, and establishing regional production units. All this growth increases the number of better-quality medical tubing products available and reduces dependency on imports, and consequently healthcare becomes affordable. Medical tubing technologies such as biodegradable and antimicrobial medical tubing grow more popular in MEA as healthcare professionals continue to prioritize infection control and eco-friendliness.
Extensive primary interviews were conducted to determine and verify the market size for several segments and sub-segments and the information gathered through secondary research.
The break-up of primary interviews is given below:
- By Department: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
- By Designation: C Level: 35%, Director Level: 30%, and Executives: 35%
- By Region: North America: 25%, Europe: 45%, Asia Pacific: 20%, South America: 5%, Middle East & Africa 5%
Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), Teknor Apex (US), Spectrum Plastics Group (US) Zeus Company LLC (US) among others are some of the key players in the medical tubing market.
The study includes an in-depth competitive analysis of these key players in the authentication and brand
protection market, with their company profiles, recent developments, and key market strategies.
Research Coverage
The market study covers the medical tubing market across various segments. It aims to estimate the market size and the growth potential of this market across different segments based on material, application, structure, end-use industry, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the medical tubing market.
Key Benefits of Buying the Report
The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall medical tubing market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (Increase in geriatric population, Increasing demand for minimally invasive medical procedures, Stringent quality standards and regulations, Advancements in extrusion technology), restraints (Limited material compatibility), opportunities (Customization and innovation in polymers and tubing structure, Increasing government expenditure for upgrading and developing healthcare infrastructure), challenges (High cost of producing and marketing medical tubing products).
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical tubing market
- Market Development: Comprehensive information about lucrative markets – the report analyses the medical tubing market across varied regions
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical tubing market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), Teknor Apex (US), Spectrum Plastics Group (US) Zeus Company LLC (US) among others are the top manufacturers covered in the medical tubing market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.3.5 UNITS CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 List of key secondary sources
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 List of primary interview participants—demand and supply side
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of interviews with experts
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 FORECAST NUMBER CALCULATION
2.4 DATA TRIANGULATION
2.5 FACTOR ANALYSIS
2.6 ASSUMPTIONS
2.7 LIMITATIONS AND RISKS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL TUBING MARKET
4.2 MEDICAL TUBING MARKET, BY MATERIAL
4.3 MEDICAL TUBING MARKET, BY APPLICATION
4.4 MEDICAL TUBING MARKET, BY REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing geriatric population
5.2.1.2 Increasing demand for minimally invasive medical procedures
5.2.1.3 Advancements in extrusion technology
5.2.1.4 Stringent quality standards and regulations
5.2.2 RESTRAINTS
5.2.2.1 Limited material compatibility
5.2.2.2 Environmental and disposal concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Advancements in biocompatible and smart materials
5.2.3.2 Increasing government expenditure to upgrade and develop healthcare infrastructure
5.2.4 CHALLENGES
5.2.4.1 High production costs and marketing complexities
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.4.2 BUYING CRITERIA
5.5 MACROECONOMIC INDICATORS
5.5.1 GLOBAL GDP TRENDS
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 REGULATORY LANDSCAPE
6.3.1 REGULATIONS
6.3.1.1 North America
6.3.1.2 Asia Pacific
6.3.1.3 Europe
6.3.2 STANDARDS
6.3.2.1 ISO standard
6.3.2.2 Food and drug administration (FDA)
6.3.2.3 ASTM (American society for testing and materials) standards
6.3.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.4 TRADE ANALYSIS
6.4.1 IMPORT SCENARIO (HS CODE 3917)
6.4.2 EXPORT SCENARIO (HS CODE 3917)
6.5 ECOSYSTEM ANALYSIS
6.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
6.7 CASE STUDY ANALYSIS
6.7.1 FREUDENBERG MEDICAL TO PROVIDE SPECIALTY BALLOON CATHETERS
6.7.2 W. L. GORE & ASSOCIATES, INC. PROVIDES GORE STA-PURE PUMP TUBING
6.8 TECHNOLOGY ANALYSIS
6.8.1 KEY TECHNOLOGIES
6.8.1.1 Extrusion technology
6.8.1.2 Advanced material technologies
6.8.2 COMPLEMENTARY TECHNOLOGIES
6.8.2.1 Smart technologies and connectivity
6.8.2.2 Surface treatment and modification
6.9 KEY CONFERENCES AND EVENTS, 2025
6.10 PATENT ANALYSIS
6.10.1 METHODOLOGY
6.10.2 DOCUMENT TYPES
6.10.3 PUBLICATION TRENDS IN LAST 11 YEARS
6.10.4 INSIGHTS
6.10.5 LEGAL STATUS OF PATENTS
6.10.6 JURISDICTION ANALYSIS
6.10.7 TOP APPLICANTS
6.11 IMPACT OF AI/GEN AI ON MEDICAL TUBING MARKET
6.12 PRICING ANALYSIS
6.12.1 AVERAGE SELLING PRICE, BY REGION, 2021–2024
6.12.2 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2024
6.12.3 AVERAGE SELLING PRICE TREND, BY MATERIAL, 2021–2024
6.13 INVESTMENT AND FUNDING SCENARIO
7 MEDICAL TUBING MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 BULK DISPOSABLE TUBING
7.2.1 DEMAND FROM HOSPITALS, HOME HEALTHCARE PROVIDERS, AND EMERGENCY CARE PROVIDERS TO BOOST MARKET
7.2.2 DIALYSIS TUBING
7.2.2.1 Growing aging population to drive demand
7.2.3 INTRAVENOUS TUBING
7.2.3.1 Technological advancements to drive market
7.3 CATHETERS & CANNULAS
7.3.1 RISING CARDIOVASCULAR DISEASES AND DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO FUEL MARKET GROWTH
7.3.2 CATHETERS
7.3.2.1 Increase in chronic diseases contributing to significant demand
7.3.2.2 Cardiovascular catheters
7.3.2.2.1 Growing elderly population and high incidence of cardiovascular diseases to propel market
7.3.2.3 IV catheters
7.3.2.3.1 Demand for direct delivery of medication and nutrients into bloodstream to fuel growth
7.3.2.4 Urinary catheters
7.3.2.4.1 Rising incidences of urinary tract infections and growing need for advanced technologies to drive demand
7.3.3 CANNULAS
7.3.3.1 Evolving healthcare sector and stringent regulatory requirements to support market growth
7.4 DRUG DELIVERY SYSTEMS
7.4.1 PRECISE DRUG DELIVERY TO TARGET SITES TO DRIVE DEMAND
7.4.2 NASOGASTRIC
7.4.2.1 Need for enteral feeding and drainage to fuel demand
7.4.3 NEBULIZERS
7.4.3.1 Conversion of liquid medications to mists for inhalation to drive market
7.5 OTHER APPLICATIONS
7.5.1 PERISTALTIC PUMP TUBING
7.5.1.1 Wide demand for minimizing contamination to boost market
7.5.2 GAS SUPPLY TUBING
7.5.2.1 Increasing minimally invasive surgeries to support market growth
7.5.3 SMOKE EVACUATION TUBING
7.5.3.1 Popularity of cosmetic procedures and medical tourism to drive market
8 MEDICAL TUBING MARKET, BY MATERIAL
8.1 INTRODUCTION
8.2 PLASTICS
8.2.1 BIOCOMPATIBILITY, CHEMICAL STABILITY, AND COST-EFFECTIVENESS TO BOOST MARKET
8.2.2 POLYVINYL CHLORIDE (PVC)
8.2.3 POLYOLEFIN
8.2.3.1 Polyethylene (PE)
8.2.3.2 Polypropylene (PP)
8.2.4 POLYAMIDE
8.2.5 POLYTETRAFLUOROETHYLENE (PTFE)
8.2.6 POLYETHER ETHER KETONE (PEEK)
8.2.7 POLYCARBONATE (PC)
8.3 RUBBERS
8.3.1 SIGNIFICANT DURABILITY AND RESILIENCE TO DRIVE DEMAND
8.3.2 THERMOPLASTIC ELASTOMER (TPE)
8.3.3 THERMOPLASTIC POLYURETHANE (TPU)
8.3.4 SILICONE
8.3.5 POLYURETHANE (PU)
8.3.6 ETHYLENE PROPYLENE DIENE MONOMER (EPDM)
8.3.7 LATEX
8.4 SPECIALTY POLYMERS
8.4.1 DEMAND FOR SPECIALIZED TREATMENT TO BOOST MARKET
8.4.2 BIOABSORBABLE POLYMERS
8.4.3 ETHYLENE VINYL ACETATE (EVA)
8.5 OTHER MATERIALS
9 MEDICAL TUBING MARKET, BY STRUCTURE
9.1 INTRODUCTION
9.2 SINGLE-LUMEN
9.2.1 DEMAND FOR ADMINISTRATION OF FLUIDS AND MEDICATION, AIRWAY MANAGEMENT, AND PATIENT NUTRITION TO DRIVE MARKET
9.3 CO-EXTRUDED
9.3.1 DURABILITY, LUBRICITY, OPACITY, RADIOPACITY, AND TENSILE STRENGTH TO BOOST MARKET
9.4 MULTI-LUMEN
9.4.1 NON-TOXICITY, BIOCOMPATIBILITY, AND INERTNESS TO FUEL MARKET DEMAND
9.5 TAPERED OR BUMP TUBING
9.5.1 ENHANCED FUNCTIONALITIES IN CVC, PICC, AND DRUG DELIVERY CATHETERS TO DRIVE MARKET
9.6 BRAIDED TUBING
9.6.1 GOOD STRENGTH, STEERABILITY, AND PRESSURE RESISTANCE TO PROPEL MARKET
10 MEDICAL TUBING MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 High disposable income and strong healthcare infrastructure to drive market
10.2.2 CANADA
10.2.2.1 Aging population and increasing healthcare expenditure to support market growth
10.2.3 MEXICO
10.2.3.1 High investments and low manufacturing costs to fuel demand
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Advanced medical facilities and R&D investments to propel market
10.3.2 FRANCE
10.3.2.1 Rising elderly population to fuel market growth
10.3.3 UK
10.3.3.1 Innovation, technological advancements, and investments to drive market
10.3.4 SPAIN
10.3.4.1 Growing aging population and improvements in healthcare system to increase consumption
10.3.5 ITALY
10.3.5.1 Growing geriatric population and strong focus on research and innovation to drive market
10.3.6 NETHERLANDS
10.3.6.1 Rising homecare treatment to increase demand
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Investments in manufacturing medical devices to support market
10.4.2 JAPAN
10.4.2.1 Implementation of AI and big data technologies in healthcare industry to increase demand
10.4.3 INDIA
10.4.3.1 Government initiatives, high purchasing power, and rising manufacturing output to fuel demand
10.4.4 SOUTH KOREA
10.4.4.1 Medical tourism to lead to market growth
10.4.5 REST OF ASIA PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 GCC COUNTRIES
10.5.1.1 Saudi Arabia
10.5.1.1.1 Government initiatives to support market growth
10.5.1.2 UAE
10.5.1.2.1 Government funding and rapidly developing private health sector to drive market
10.5.2 SOUTH AFRICA
10.5.2.1 Increasing awareness, testing, and treatment programs to drive market
10.5.3 EGYPT
10.5.3.1 Technological advancements and improving healthcare sector to fuel demand
10.5.4 REST OF MIDDLE EAST & AFRICA
10.6 SOUTH AMERICA
10.6.1 BRAZIL
10.6.1.1 Growing healthcare system to increase consumption
10.6.2 ARGENTINA
10.6.2.1 Rising prevalence of chronic diseases, aging population, and advances in medical sector to drive market
10.6.3 REST OF SOUTH AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2025
11.3 REVENUE ANALYSIS, 2024
11.4 MARKET SHARE ANALYSIS, 2024
11.4.1 SAINT-GOBAIN
11.4.2 FREUDENBERG MEDICAL
11.4.3 THE LUBRIZOL CORPORATION
11.4.4 W. L. GORE & ASSOCIATES, INC.
11.4.5 TE CONNECTIVITY
11.5 COMPANY VALUATION AND FINANCIAL METRICS
11.6 BRAND COMPARISON
11.6.1 MEDICAL TUBING MARKET: BRAND COMPARISON
11.6.2 BIO-SIL TUBING
11.6.3 HELIXFLEX
11.6.4 ISOPLAST ETPU MEDICAL TUBING
11.6.5 GORE STA-PURE PUMP TUBING SERIES PFL
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.7.5.1 Company footprint
11.7.5.2 Region footprint
11.7.5.3 Structure footprint
11.7.5.4 Material footprint
11.7.5.5 Application footprint
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.8.1 PROGRESSIVE COMPANIES
11.8.2 RESPONSIVE COMPANIES
11.8.3 DYNAMIC COMPANIES
11.8.4 STARTING BLOCKS
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.8.5.1 Detailed list of key startups/SMEs
11.8.5.2 Competitive benchmarking of startups/SMEs
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS
11.9.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 SAINT-GOBAIN
12.1.1.1 Business overview
12.1.1.2 Products/Solutions/Services offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 FREUDENBERG MEDICAL
12.1.2.1 Business overview
12.1.2.2 Products/Solutions/Services offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 THE LUBRIZOL CORPORATION
12.1.3.1 Business overview
12.1.3.2 Products/Solutions/Services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.3.2 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 W. L. GORE & ASSOCIATES, INC.
12.1.4.1 Business overview
12.1.4.2 Products/Solutions/Services offered
12.1.4.3 MnM view
12.1.4.3.1 Right to win
12.1.4.3.2 Strategic choices
12.1.4.3.3 Weaknesses and competitive threats
12.1.5 NORDSON CORPORATION
12.1.5.1 Business overview
12.1.5.2 Products/Solutions/Services offered
12.1.5.3 Recent developments
12.1.5.3.1 Deals
12.1.5.4 MnM view
12.1.5.4.1 Right to win
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 TE CONNECTIVITY
12.1.6.1 Business overview
12.1.6.2 Products/Solutions/Services offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches
12.1.6.4 MnM view
12.1.7 ELKEM ASA
12.1.7.1 Business overview
12.1.7.2 Products/Solutions/Services offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.7.3.2 Expansions
12.1.7.4 MnM view
12.1.8 TRELLEBORG AB
12.1.8.1 Business overview
12.1.8.2 Products/Solutions/Services offered
12.1.8.3 Recent developments
12.1.8.3.1 Deals
12.1.8.3.2 Other developments
12.1.8.4 MnM view
12.1.9 RAUMEDIC AG
12.1.9.1 Business overview
12.1.9.2 Products/Solutions/Services offered
12.1.9.3 Recent developments
12.1.9.3.1 Product launches
12.1.9.3.2 Deals
12.1.9.3.3 Expansions
12.1.9.4 MnM view
12.1.10 TEKNOR APEX
12.1.10.1 Business overview
12.1.10.2 Products/Solutions/Services offered
12.1.10.3 Recent developments
12.1.10.3.1 Product launches
12.1.10.3.2 Deals
12.1.10.4 MnM view
12.1.11 SPECTRUM PLASTICS GROUP
12.1.11.1 Business overview
12.1.11.2 Products/Solutions/Services offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.11.3.2 Expansions
12.1.11.4 MnM view
12.1.12 ZEUS COMPANY LLC
12.1.12.1 Business overview
12.1.12.2 Products/Solutions/Services offered
12.1.12.3 Recent developments
12.1.12.3.1 Product launches
12.1.12.3.2 Expansions
12.1.12.4 MnM view
12.2 OTHER PLAYERS
12.2.1 ATAG SPA
12.2.2 DAVIS STANDARD
12.2.3 FBK MEDICAL TUBING
12.2.4 PROTERIAL CABLE AMERICA, INC.
12.2.5 ICO RALLY
12.2.6 ICU MEDICAL, INC.
12.2.7 KRATON CORPORATION
12.2.8 MICROLUMEN INC.
12.2.9 MDC INDUSTRIES
12.2.10 NEWAGE INDUSTRIES
12.2.11 OPTINOVA
12.2.12 PARKER HANNIFIN CORP.
12.2.13 TEEL PLASTICS
12.2.14 VESTA INC.
12.2.15 SMOOTH-BOR PLASTICS
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.3.5 UNITS CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 List of key secondary sources
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 List of primary interview participants—demand and supply side
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of interviews with experts
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 FORECAST NUMBER CALCULATION
2.4 DATA TRIANGULATION
2.5 FACTOR ANALYSIS
2.6 ASSUMPTIONS
2.7 LIMITATIONS AND RISKS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL TUBING MARKET
4.2 MEDICAL TUBING MARKET, BY MATERIAL
4.3 MEDICAL TUBING MARKET, BY APPLICATION
4.4 MEDICAL TUBING MARKET, BY REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing geriatric population
5.2.1.2 Increasing demand for minimally invasive medical procedures
5.2.1.3 Advancements in extrusion technology
5.2.1.4 Stringent quality standards and regulations
5.2.2 RESTRAINTS
5.2.2.1 Limited material compatibility
5.2.2.2 Environmental and disposal concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Advancements in biocompatible and smart materials
5.2.3.2 Increasing government expenditure to upgrade and develop healthcare infrastructure
5.2.4 CHALLENGES
5.2.4.1 High production costs and marketing complexities
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.4.2 BUYING CRITERIA
5.5 MACROECONOMIC INDICATORS
5.5.1 GLOBAL GDP TRENDS
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 REGULATORY LANDSCAPE
6.3.1 REGULATIONS
6.3.1.1 North America
6.3.1.2 Asia Pacific
6.3.1.3 Europe
6.3.2 STANDARDS
6.3.2.1 ISO standard
6.3.2.2 Food and drug administration (FDA)
6.3.2.3 ASTM (American society for testing and materials) standards
6.3.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.4 TRADE ANALYSIS
6.4.1 IMPORT SCENARIO (HS CODE 3917)
6.4.2 EXPORT SCENARIO (HS CODE 3917)
6.5 ECOSYSTEM ANALYSIS
6.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
6.7 CASE STUDY ANALYSIS
6.7.1 FREUDENBERG MEDICAL TO PROVIDE SPECIALTY BALLOON CATHETERS
6.7.2 W. L. GORE & ASSOCIATES, INC. PROVIDES GORE STA-PURE PUMP TUBING
6.8 TECHNOLOGY ANALYSIS
6.8.1 KEY TECHNOLOGIES
6.8.1.1 Extrusion technology
6.8.1.2 Advanced material technologies
6.8.2 COMPLEMENTARY TECHNOLOGIES
6.8.2.1 Smart technologies and connectivity
6.8.2.2 Surface treatment and modification
6.9 KEY CONFERENCES AND EVENTS, 2025
6.10 PATENT ANALYSIS
6.10.1 METHODOLOGY
6.10.2 DOCUMENT TYPES
6.10.3 PUBLICATION TRENDS IN LAST 11 YEARS
6.10.4 INSIGHTS
6.10.5 LEGAL STATUS OF PATENTS
6.10.6 JURISDICTION ANALYSIS
6.10.7 TOP APPLICANTS
6.11 IMPACT OF AI/GEN AI ON MEDICAL TUBING MARKET
6.12 PRICING ANALYSIS
6.12.1 AVERAGE SELLING PRICE, BY REGION, 2021–2024
6.12.2 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2024
6.12.3 AVERAGE SELLING PRICE TREND, BY MATERIAL, 2021–2024
6.13 INVESTMENT AND FUNDING SCENARIO
7 MEDICAL TUBING MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 BULK DISPOSABLE TUBING
7.2.1 DEMAND FROM HOSPITALS, HOME HEALTHCARE PROVIDERS, AND EMERGENCY CARE PROVIDERS TO BOOST MARKET
7.2.2 DIALYSIS TUBING
7.2.2.1 Growing aging population to drive demand
7.2.3 INTRAVENOUS TUBING
7.2.3.1 Technological advancements to drive market
7.3 CATHETERS & CANNULAS
7.3.1 RISING CARDIOVASCULAR DISEASES AND DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO FUEL MARKET GROWTH
7.3.2 CATHETERS
7.3.2.1 Increase in chronic diseases contributing to significant demand
7.3.2.2 Cardiovascular catheters
7.3.2.2.1 Growing elderly population and high incidence of cardiovascular diseases to propel market
7.3.2.3 IV catheters
7.3.2.3.1 Demand for direct delivery of medication and nutrients into bloodstream to fuel growth
7.3.2.4 Urinary catheters
7.3.2.4.1 Rising incidences of urinary tract infections and growing need for advanced technologies to drive demand
7.3.3 CANNULAS
7.3.3.1 Evolving healthcare sector and stringent regulatory requirements to support market growth
7.4 DRUG DELIVERY SYSTEMS
7.4.1 PRECISE DRUG DELIVERY TO TARGET SITES TO DRIVE DEMAND
7.4.2 NASOGASTRIC
7.4.2.1 Need for enteral feeding and drainage to fuel demand
7.4.3 NEBULIZERS
7.4.3.1 Conversion of liquid medications to mists for inhalation to drive market
7.5 OTHER APPLICATIONS
7.5.1 PERISTALTIC PUMP TUBING
7.5.1.1 Wide demand for minimizing contamination to boost market
7.5.2 GAS SUPPLY TUBING
7.5.2.1 Increasing minimally invasive surgeries to support market growth
7.5.3 SMOKE EVACUATION TUBING
7.5.3.1 Popularity of cosmetic procedures and medical tourism to drive market
8 MEDICAL TUBING MARKET, BY MATERIAL
8.1 INTRODUCTION
8.2 PLASTICS
8.2.1 BIOCOMPATIBILITY, CHEMICAL STABILITY, AND COST-EFFECTIVENESS TO BOOST MARKET
8.2.2 POLYVINYL CHLORIDE (PVC)
8.2.3 POLYOLEFIN
8.2.3.1 Polyethylene (PE)
8.2.3.2 Polypropylene (PP)
8.2.4 POLYAMIDE
8.2.5 POLYTETRAFLUOROETHYLENE (PTFE)
8.2.6 POLYETHER ETHER KETONE (PEEK)
8.2.7 POLYCARBONATE (PC)
8.3 RUBBERS
8.3.1 SIGNIFICANT DURABILITY AND RESILIENCE TO DRIVE DEMAND
8.3.2 THERMOPLASTIC ELASTOMER (TPE)
8.3.3 THERMOPLASTIC POLYURETHANE (TPU)
8.3.4 SILICONE
8.3.5 POLYURETHANE (PU)
8.3.6 ETHYLENE PROPYLENE DIENE MONOMER (EPDM)
8.3.7 LATEX
8.4 SPECIALTY POLYMERS
8.4.1 DEMAND FOR SPECIALIZED TREATMENT TO BOOST MARKET
8.4.2 BIOABSORBABLE POLYMERS
8.4.3 ETHYLENE VINYL ACETATE (EVA)
8.5 OTHER MATERIALS
9 MEDICAL TUBING MARKET, BY STRUCTURE
9.1 INTRODUCTION
9.2 SINGLE-LUMEN
9.2.1 DEMAND FOR ADMINISTRATION OF FLUIDS AND MEDICATION, AIRWAY MANAGEMENT, AND PATIENT NUTRITION TO DRIVE MARKET
9.3 CO-EXTRUDED
9.3.1 DURABILITY, LUBRICITY, OPACITY, RADIOPACITY, AND TENSILE STRENGTH TO BOOST MARKET
9.4 MULTI-LUMEN
9.4.1 NON-TOXICITY, BIOCOMPATIBILITY, AND INERTNESS TO FUEL MARKET DEMAND
9.5 TAPERED OR BUMP TUBING
9.5.1 ENHANCED FUNCTIONALITIES IN CVC, PICC, AND DRUG DELIVERY CATHETERS TO DRIVE MARKET
9.6 BRAIDED TUBING
9.6.1 GOOD STRENGTH, STEERABILITY, AND PRESSURE RESISTANCE TO PROPEL MARKET
10 MEDICAL TUBING MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 High disposable income and strong healthcare infrastructure to drive market
10.2.2 CANADA
10.2.2.1 Aging population and increasing healthcare expenditure to support market growth
10.2.3 MEXICO
10.2.3.1 High investments and low manufacturing costs to fuel demand
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Advanced medical facilities and R&D investments to propel market
10.3.2 FRANCE
10.3.2.1 Rising elderly population to fuel market growth
10.3.3 UK
10.3.3.1 Innovation, technological advancements, and investments to drive market
10.3.4 SPAIN
10.3.4.1 Growing aging population and improvements in healthcare system to increase consumption
10.3.5 ITALY
10.3.5.1 Growing geriatric population and strong focus on research and innovation to drive market
10.3.6 NETHERLANDS
10.3.6.1 Rising homecare treatment to increase demand
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Investments in manufacturing medical devices to support market
10.4.2 JAPAN
10.4.2.1 Implementation of AI and big data technologies in healthcare industry to increase demand
10.4.3 INDIA
10.4.3.1 Government initiatives, high purchasing power, and rising manufacturing output to fuel demand
10.4.4 SOUTH KOREA
10.4.4.1 Medical tourism to lead to market growth
10.4.5 REST OF ASIA PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 GCC COUNTRIES
10.5.1.1 Saudi Arabia
10.5.1.1.1 Government initiatives to support market growth
10.5.1.2 UAE
10.5.1.2.1 Government funding and rapidly developing private health sector to drive market
10.5.2 SOUTH AFRICA
10.5.2.1 Increasing awareness, testing, and treatment programs to drive market
10.5.3 EGYPT
10.5.3.1 Technological advancements and improving healthcare sector to fuel demand
10.5.4 REST OF MIDDLE EAST & AFRICA
10.6 SOUTH AMERICA
10.6.1 BRAZIL
10.6.1.1 Growing healthcare system to increase consumption
10.6.2 ARGENTINA
10.6.2.1 Rising prevalence of chronic diseases, aging population, and advances in medical sector to drive market
10.6.3 REST OF SOUTH AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2025
11.3 REVENUE ANALYSIS, 2024
11.4 MARKET SHARE ANALYSIS, 2024
11.4.1 SAINT-GOBAIN
11.4.2 FREUDENBERG MEDICAL
11.4.3 THE LUBRIZOL CORPORATION
11.4.4 W. L. GORE & ASSOCIATES, INC.
11.4.5 TE CONNECTIVITY
11.5 COMPANY VALUATION AND FINANCIAL METRICS
11.6 BRAND COMPARISON
11.6.1 MEDICAL TUBING MARKET: BRAND COMPARISON
11.6.2 BIO-SIL TUBING
11.6.3 HELIXFLEX
11.6.4 ISOPLAST ETPU MEDICAL TUBING
11.6.5 GORE STA-PURE PUMP TUBING SERIES PFL
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.7.5.1 Company footprint
11.7.5.2 Region footprint
11.7.5.3 Structure footprint
11.7.5.4 Material footprint
11.7.5.5 Application footprint
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.8.1 PROGRESSIVE COMPANIES
11.8.2 RESPONSIVE COMPANIES
11.8.3 DYNAMIC COMPANIES
11.8.4 STARTING BLOCKS
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.8.5.1 Detailed list of key startups/SMEs
11.8.5.2 Competitive benchmarking of startups/SMEs
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS
11.9.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 SAINT-GOBAIN
12.1.1.1 Business overview
12.1.1.2 Products/Solutions/Services offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 FREUDENBERG MEDICAL
12.1.2.1 Business overview
12.1.2.2 Products/Solutions/Services offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 THE LUBRIZOL CORPORATION
12.1.3.1 Business overview
12.1.3.2 Products/Solutions/Services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.3.2 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 W. L. GORE & ASSOCIATES, INC.
12.1.4.1 Business overview
12.1.4.2 Products/Solutions/Services offered
12.1.4.3 MnM view
12.1.4.3.1 Right to win
12.1.4.3.2 Strategic choices
12.1.4.3.3 Weaknesses and competitive threats
12.1.5 NORDSON CORPORATION
12.1.5.1 Business overview
12.1.5.2 Products/Solutions/Services offered
12.1.5.3 Recent developments
12.1.5.3.1 Deals
12.1.5.4 MnM view
12.1.5.4.1 Right to win
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 TE CONNECTIVITY
12.1.6.1 Business overview
12.1.6.2 Products/Solutions/Services offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches
12.1.6.4 MnM view
12.1.7 ELKEM ASA
12.1.7.1 Business overview
12.1.7.2 Products/Solutions/Services offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.7.3.2 Expansions
12.1.7.4 MnM view
12.1.8 TRELLEBORG AB
12.1.8.1 Business overview
12.1.8.2 Products/Solutions/Services offered
12.1.8.3 Recent developments
12.1.8.3.1 Deals
12.1.8.3.2 Other developments
12.1.8.4 MnM view
12.1.9 RAUMEDIC AG
12.1.9.1 Business overview
12.1.9.2 Products/Solutions/Services offered
12.1.9.3 Recent developments
12.1.9.3.1 Product launches
12.1.9.3.2 Deals
12.1.9.3.3 Expansions
12.1.9.4 MnM view
12.1.10 TEKNOR APEX
12.1.10.1 Business overview
12.1.10.2 Products/Solutions/Services offered
12.1.10.3 Recent developments
12.1.10.3.1 Product launches
12.1.10.3.2 Deals
12.1.10.4 MnM view
12.1.11 SPECTRUM PLASTICS GROUP
12.1.11.1 Business overview
12.1.11.2 Products/Solutions/Services offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.11.3.2 Expansions
12.1.11.4 MnM view
12.1.12 ZEUS COMPANY LLC
12.1.12.1 Business overview
12.1.12.2 Products/Solutions/Services offered
12.1.12.3 Recent developments
12.1.12.3.1 Product launches
12.1.12.3.2 Expansions
12.1.12.4 MnM view
12.2 OTHER PLAYERS
12.2.1 ATAG SPA
12.2.2 DAVIS STANDARD
12.2.3 FBK MEDICAL TUBING
12.2.4 PROTERIAL CABLE AMERICA, INC.
12.2.5 ICO RALLY
12.2.6 ICU MEDICAL, INC.
12.2.7 KRATON CORPORATION
12.2.8 MICROLUMEN INC.
12.2.9 MDC INDUSTRIES
12.2.10 NEWAGE INDUSTRIES
12.2.11 OPTINOVA
12.2.12 PARKER HANNIFIN CORP.
12.2.13 TEEL PLASTICS
12.2.14 VESTA INC.
12.2.15 SMOOTH-BOR PLASTICS
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
